Skip to Main Content

Author Details

Andrey Sivachenko
Cystic Fibrosis Foundation
2003
40
35
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
30563749Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells.J Cyst Fibros2019
30563749Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells.J Cyst Fibros2019
24498085A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.PLoS One2014
25512523Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.Proc Natl Acad Sci U S A2014
24323028Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.J Clin Oncol2014
24498085A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.PLoS One2014
24816817Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA.PLoS One2014
25186949The genomic landscape of pediatric Ewing sarcoma.Cancer Discov2014
24836576Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Nat Med2014
24695405PRADA: pipeline for RNA sequencing data analysis.Bioinformatics2014
25512523Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.Proc Natl Acad Sci U S A2014
25186949The genomic landscape of pediatric Ewing sarcoma.Cancer Discov2014
24836576Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Nat Med2014
24816817Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA.PLoS One2014
24695405PRADA: pipeline for RNA sequencing data analysis.Bioinformatics2014
24323028Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.J Clin Oncol2014
23334666The genetic landscape of high-risk neuroblastoma.Nat Genet2013
23770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013
24185511Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.Nat Genet2013
23786770Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Cancer Res2013
23685885Comparative analysis of RNA sequencing methods for degraded or low-input samples.Nat Methods2013
23396013Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.Nat Biotechnol2013
23525077Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.Nat Genet2013
23622249Punctuated evolution of prostate cancer genomes.Cell2013
23415222Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.Cell2013
23334666The genetic landscape of high-risk neuroblastoma.Nat Genet2013
24185511Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.Nat Genet2013
23685885Comparative analysis of RNA sequencing methods for degraded or low-input samples.Nat Methods2013
23622249Punctuated evolution of prostate cancer genomes.Cell2013
23770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013
23786770Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Cancer Res2013
23396013Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.Nat Biotechnol2013
23415222Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.Cell2013
23525077Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.Nat Genet2013
22610119Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.Nat Genet2012
22539670RNA-SeQC: RNA-seq metrics for quality control and process optimization.Bioinformatics2012
22622578Melanoma genome sequencing reveals frequent PREX2 mutations.Nature2012
22722202Sequence analysis of mutations and translocations across breast cancer subtypes.Nature2012
22820256Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.Nature2012
22610119Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.Nat Genet2012
22817889A landscape of driver mutations in melanoma.Cell2012
22980975Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.Cell2012
22980975Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.Cell2012
22722202Sequence analysis of mutations and translocations across breast cancer subtypes.Nature2012
22820256Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.Nature2012
22817889A landscape of driver mutations in melanoma.Cell2012
22539670RNA-SeQC: RNA-seq metrics for quality control and process optimization.Bioinformatics2012
22622578Melanoma genome sequencing reveals frequent PREX2 mutations.Nature2012
21478889A framework for variation discovery and genotyping using next-generation DNA sequencing data.Nat Genet2011
21307934The genomic complexity of primary human prostate cancer.Nature2011
  • 1 - 50 of 80

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 2
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 19
Broad Institute of Harvard and MIT
Career Start Year 2007
Number of shared co-authors 16
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Pacific Northwest National Laboratory (PNNL)
Career Start Year 2006
Number of shared co-authors 3
Karolinska Institutet
Career Start Year 2006
Number of shared co-authors 4
University of Bristol
Career Start Year 2006
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 5
Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 7
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 1
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 22
Pfizer Inc.
Career Start Year 2004
Number of shared co-authors 0
Spanish National Cancer Research Centre (CNIO)
Career Start Year 2003
Number of shared co-authors 9
Schroeder Arthritis Institute
Career Start Year 2002
Number of shared co-authors 0
Lewis-Sigler Institute for Integrative Genomics, Princeton University
Career Start Year 2001
Number of shared co-authors 5
Weill Institute for Cell and Molecular Biology, Cornell University
Career Start Year 2001
Number of shared co-authors 6
University of Toronto
Career Start Year 2000
Number of shared co-authors 20
University of California at Santa Cruz
Career Start Year 2000
Number of shared co-authors 36
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 5
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 2
Max Planck Institute for Molecular Genetics
Career Start Year 1998
Number of shared co-authors 1
Center for Precision Health, The University of Texas Health Science Center at Houston
Career Start Year 1998
Number of shared co-authors 3
Oregon Health and Science University
Career Start Year 1998
Number of shared co-authors 4
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 4
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 20
University of California San Diego
Career Start Year 1996
Number of shared co-authors 20
University of Lausanne
Career Start Year 1994
Number of shared co-authors 2
Columbia University
Career Start Year 1993
Number of shared co-authors 24
Center for Computational Biomedicine, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 6
The College of New Jersey
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 27
Co-authored papers 24
Co-authored papers 23
Broad Institute of MIT and Harvard
Co-authored papers 22
Broad Institute
Co-authored papers 21
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 20
Co-authored papers 17
The Broad Institute of Harvard and MIT
Co-authored papers 16
Co-authored papers 14
Co-authored papers 14
Broad Institute of Harvard and MIT
Co-authored papers 14
Co-authored papers 13
Co-authored papers 12
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 12
Co-authored papers 12
Broad Institute of MIT and Harvard
Co-authored papers 12
The Broad Institute of Harvard and MIT
Co-authored papers 12
Co-authored papers 11
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 10
Co-authored papers 9
Co-authored papers 7
Co-authored papers 7
The Broad Institute of Harvard and MIT
Co-authored papers 6
The Broad Institute of MIT and Harvard
Co-authored papers 6
Co-authored papers 6
Broad Institute
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Broad Institute of MIT and Harvard
Co-authored papers 6
Co-authored papers 6